Prolonged Hospital Stay After Thoracoscopic Anatomical Lung Resections

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Ghent

About this trial

In this study, the reasons for prolonged hospital stay after thoracoscopic (video- or robot-assisted) anatomical lung resections are investigated. Currently, whenever possible, these anatomical lung resections are performed thoracoscopically, as they offer significant improvements in terms of postoperative pain, number of postoperative complications, rehabilitation, tolerance for adjuvant chemotherapy, and length of hospital stay. The development of an 'Enhanced Recovery After Surgery' (ERAS) protocol for lung surgery has further reduced hospital stay and the need for opioids for analgesia. Despite the optimal implementation of the ERAS protocol, there are still patients who need to stay in the hospital longer than the median. The aim of this research is to investigate the reasons for this.

Eligibility criteria

Qualifiers

Patients referred for elective minimally invasive (uniportal or multiportal video- or robot-assisted) anatomical lung resection (lobectomy or segmentectomy)

Informed consent obtained pre-operatively

Age 18 years or older

Disqualifiers

Patients younger than 18 years old

Traumatic event as indication for lung resection

Non-anatomical lung resections

Thoracotomy

Trial design

Treatments tested in this trial

  • VATS/RATS anatomical lung resection

Treatment groups

140 Participants
are divided into 1 treatment group

Sponsors and collaborators

University Hospital, Ghent

Lead sponsor

AZ Sint-Lucas Brugge

Collaborator